Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1959 1
1966 1
1970 1
1972 1
1975 1
1978 6
1979 1
1980 3
1985 5
1986 67
1987 218
1988 267
1989 293
1990 295
1991 329
1992 344
1993 342
1994 413
1995 351
1996 343
1997 359
1998 349
1999 309
2000 310
2001 387
2002 436
2003 490
2004 455
2005 413
2006 441
2007 575
2008 558
2009 561
2010 602
2011 513
2012 555
2013 613
2014 743
2015 734
2016 756
2017 750
2018 802
2019 429
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

14,003 results
Results by year
Filters applied: . Clear all
Page 1
Maintaining Patency of Vascular Access for Haemodialysis.
Inston N, et al. Cardiovasc Eng Technol 2017. PMID 28721509 Free PMC article.
All types of vascular access, a necessity for haemodialysis, are prone to thrombosis and if untreated this results in failure. ...
All types of vascular access, a necessity for haemodialysis, are prone to thrombosis and if untreated this results in failure. ...
Novel drug targets for ductus arteriosus manipulation: Looking beyond prostaglandins
Shelton EL, et al. Semin Perinatol 2018 - Review. PMID 29880312 Free PMC article.
And yet, prolonged patency of the DA (PDA) remains a significant clinical problem, complicated by imperfect therapies and wide variations in treatment strategy. There are few pharmacology-based tools available for treating PDA (indomethacin, ibuprofen, and acetaminophen), or for maintaining DA patency (PGE(1)) as is needed to facilitate corrective surgery for ductus-dependent congenital heart defects. ...
And yet, prolonged patency of the DA (PDA) remains a significant clinical problem, complicated by imperfect therapies and wide variat …
Medical Adjuvant Treatment to Improve the Patency of Arteriovenous Fistulae and Grafts: A Systematic Review and Meta-analysis.
Tanner NC and da Silva AF. Eur J Vasc Endovasc Surg 2016 - Review. PMID 27289558 Free article.
Patency can be variable, and this systematic review aimed to determine the effects of adjuvant drug treatment on the patency of AVFs and grafts. METHODS: The Cochrane Peripheral Vascular Diseases Group searched the Specialised Register and CENTRAL for all randomised controlled trials (RCTs) investigating the effect of active drug versus placebo on patency. ...
Patency can be variable, and this systematic review aimed to determine the effects of adjuvant drug treatment on the patency o
Effect of regional versus local anaesthesia on outcome after arteriovenous fistula creation: a randomised controlled trial
Aitken E, et al. Lancet 2016. PMID 27492881
BACKGROUND: Arteriovenous fistulae are the optimum form of vascular access in end-stage renal failure. However, they have a high early failure rate. ...This study investigated whether regional compared with local anaesthesia improved medium-term arteriovenous fistula patency. ...
BACKGROUND: Arteriovenous fistulae are the optimum form of vascular access in end-stage renal failure. However, they have a high earl …
Effect of systemic immunosuppressive drugs on the patency of hemodialysis accesses
.
Lee H, et al. Clin Nephrol 2018. PMID 29057732
This study assessed the influence of conventional immunosuppressive drugs on the patency of hemodialysis accesses in patients with a history of organ transplantation. ...The 5-year primary patency rate was 74.0% for the NT group and 51.5% for the IT group (p < 0.001). The characteristics of the matched cohorts (135 IT patients and 536 NT patients) were well balanced; the 5-year primary patency rates were 70.0% and 54.9% for the NT and IT groups, respectively (p = 0.030). ...
This study assessed the influence of conventional immunosuppressive drugs on the patency of hemodialysis accesses in patients with a …
14,003 results
Jump to page
Feedback